Interleukin-6 Depletion Selectively Improves Hepatic Insulin Action in Obesity
- 1 August 2005
- journal article
- Published by The Endocrine Society in Endocrinology
- Vol. 146 (8), 3417-3427
- https://doi.org/10.1210/en.2004-1468
Abstract
Obesity and insulin resistance are considered chronic inflammatory states, in part because circulating IL-6 is elevated. Exogenous IL-6 can induce hepatic insulin resistance in vitro and in vivo. The importance of endogenous IL-6, however, to insulin resistance of obesity is unresolved. To test the hypothesis that IL-6 contributes to the inflammation and insulin resistance of obesity, IL-6 was depleted in Lep(ob) mice by injection of IL-6-neutralizing antibody. In untreated Lep(ob) mice, signal transducer and activator of transcription-3 (STAT3) activation was increased compared with that in lean controls, consistent with an inflammatory state. With IL-6 depletion, activation of STAT3 in liver and adipose tissue and expression of haptoglobin were reduced. Expression of the IL-6-dependent, hepatic acute phase protein fibrinogen was also decreased. Using the hyperinsulinemic-euglycemic clamp technique, insulin-dependent suppression of endogenous glucose production was 89% in IL-6-depleted Lep(ob) mice, in contrast to only 32% in Lep(ob) controls, indicating a marked increase in hepatic insulin sensitivity. A significant change in glucose uptake in skeletal muscle after IL-6 neutralization was not observed. In a direct comparison of hepatic insulin signaling in Lep(ob) mice treated with anti-IL-6 vs. IgG-treated controls, insulin-dependent insulin receptor autophosphorylation and activation of Akt (pSer473) were increased by nearly 50% with IL-6 depletion. In adipose tissue, insulin receptor signaling showed no significant change despite major reductions in STAT3 phosphorylation and haptoglobin expression. In diet-induced obese mice, depletion of IL-6 improved insulin responsiveness in 2-h insulin tolerance tests. In conclusion, these results indicate that IL-6 plays an important and selective role in hepatic insulin resistance of obesity.Keywords
This publication has 36 references indexed in Scilit:
- Obesity is associated with macrophage accumulation in adipose tissueJCI Insight, 2003
- Interleukin-6 (IL-6) Induces Insulin Resistance in 3T3-L1 Adipocytes and Is, Like IL-8 and Tumor Necrosis Factor-α, Overexpressed in Human Fat Cells from Insulin-resistant SubjectsJournal of Biological Chemistry, 2003
- Plasma PAI-1 Levels Are More Strongly Related to Liver Steatosis Than to Adipose Tissue AccumulationArteriosclerosis, Thrombosis, and Vascular Biology, 2003
- Association Between Adiponectin and Mediators of Inflammation in Obese WomenDiabetes, 2003
- Suppressor of Cytokine Signaling-3 (SOCS-3), a Potential Mediator of Interleukin-6-dependent Insulin Resistance in HepatocytesJournal of Biological Chemistry, 2003
- Interleukin-6 Induces Cellular Insulin Resistance in HepatocytesDiabetes, 2002
- SOCS-3 Inhibits Insulin Signaling and Is Up-regulated in Response to Tumor Necrosis Factor-α in the Adipose Tissue of Obese MiceJournal of Biological Chemistry, 2001
- C-Reactive Protein, Interleukin 6, and Risk of Developing Type 2 Diabetes MellitusJAMA, 2001
- Tumor necrosis factor alpha inhibits signaling from the insulin receptor.Proceedings of the National Academy of Sciences, 1994
- Hyperfibrinogenemia: An important risk factor for vascular complications in diabetesDiabetes Care, 1992